[ORGANIZATION]
The Lancet Psychiatry
Featured in 3 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
314 clusters · 1158 sources · last updated
Latest: GLP-1 medications and weight management strategies
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. Cardiovascular benefits rema
Antipsychotic medication metabolic risk study
2 clusters · 6 sources · last updated
Latest: Antipsychotic treatment linked to rapid metabolic changes in first 90 days
A study published in The Lancet Psychiatry by researchers from University College London has identified the first 90 days of second-generation antipsychotic treatment as a critical window for rapid metabolic changes. Ana